Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gyros taps further into GE's Asian biopharma channels

This article was originally published in Clinica

Executive Summary

GE Healthcare is to distribute Gyros's nanolitre-scale immunoassays to biopharmaceutical companies in China, Taiwan and Hong Kong. GE is already selling the Swedish company's products in Japan, after becoming Gyros's exclusive distributor for that market in July (www.clinica.co.uk, 14 July 2011). Gyros's automated immunoassays are used during the development of biotherapeutics and vaccines. They are designed to cut the time to result significantly, increase productivity and reduce development times, according to Uppsala-based Gyros. The products, which are also available in the US and Europe, complement GE's own offerings to the biopharma market, its Biacore and Microcal analytical systems.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT097808

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel